tiprankstipranks
Bio-Rad Laboratories (BIO)
NYSE:BIO

Bio-Rad Laboratories (BIO) Financial Statements

835 Followers

Bio-Rad Laboratories Financial Overview

Bio-Rad Laboratories's market cap is currently ―. The company's EPS TTM is $-10.367; its P/E ratio is -25.46; Bio-Rad Laboratories is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $2.02. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 610.82M$ 681.18M$ 632.12M$ 681.11M$ 676.84M
Gross Profit$ 325.97M$ 366.36M$ 335.68M$ 362.48M$ 362.42M
EBIT$ 503.36M$ 440.75M$ 149.50M$ -1.49B$ 72.49M
EBITDA$ 540.46M$ 477.95M$ 149.50M$ -1.49B$ 72.49M
Net Income Common Stockholders$ 383.92M$ 349.71M$ 106.26M$ -1.16B$ 1.35B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.65B$ 1.61B$ 1.76B$ 1.72B$ 1.85B
Total Assets$ 11.83B$ 12.30B$ 11.12B$ 11.98B$ 13.67B
Total Debt$ 1.40B$ 1.41B$ 1.41B$ 1.38B$ 1.38B
Net Debt$ -245.95M$ -201.75M$ -353.51M$ -340.43M$ -469.74M
Total Liabilities$ 3.56B$ 3.56B$ 3.48B$ 3.53B$ 3.90B
Stockholders Equity$ 9.05B$ 8.74B$ 8.42B$ 8.45B$ 9.76B
Cash Flow-
Free Cash Flow$ 29.64M$ 38.80M$ 141.06M$ 63.47M$ 62.39M
Operating Cash Flow$ 69.79M$ 81.05M$ 185.07M$ 98.07M$ 98.12M
Investing Cash Flow$ -43.09M$ 72.20M$ -9.50M$ 27.98M$ -70.47M
Financing Cash Flow$ 21.00K$ -200.62M$ -26.60M$ -202.74M$ 4.31M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History

Bio-Rad Laboratories Debt to Assets

Bio-Rad Laboratories Cash Flow

Bio-Rad Laboratories Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis